Operating Data

Biomerica Inc

Biomerica Inc (BMRA)

$5.51
-0.09 (-1.61%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 6.475.124.965.145.795.565.206.696.796.907.007.117.21
Revenue (%)
EBITDA 0.75-0.22-0.37-0.56-0.69-1.25-2.21-2.20-1.03-1.04-1.06-1.07-1.09
EBITDA (%)
EBIT 0.53-0.43-0.62-0.80-0.91-1.43-2.37-2.33-1.28-1.29-1.31-1.33-1.35
EBIT (%)
Depreciation 0.220.210.250.230.220.190.160.130.250.250.260.260.26
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)